CURE’s skin cancer page is an extensive resource of cancer information featuring the latest skin cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on skin cancer.
March 28th 2025
Favorable initial results from a phase 1/2 trial of solnerstotug in PD-L1–resistant tumors showed a 14% response rate and 62% disease control rate.
December 30th 2024
In Watching for the Side Effects of Immunotherapy, You are Your Own First Line of Defense
December 13th 2016WITH THREE “CHECKPOINT-INHIBITING” IMMUNOTHERAPIES NOW FDA-approved for the treatment of melanoma, we all need to be attuned to the unique grouping of side effects that can arise when patients take these medications.